• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Rett Syndrome - Articles and news items

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Industry news / 18 May 2016 / Mandy Parrett, Editorial Assistant

Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.